Thomas E. Keane
Professor and Chairman of the Department of Urology at the Medical University of South Carolina, Charleston, SC USA
Thomas E. Keane, MBBCh, FRCSI, FACS specializes in managing prostate, bladder, and renal cancers. An avid researcher, Dr. Keane has served as principal investigator or coinvestigator on more than 20 major clinical and preclinical studies, funded by grants from the National Institutes of Health as well as industry-funded. Much of his work focuses on innovative concepts in translational research, including utilizing human tumor xenografts to investigate the efficacy of new therapies as they relate to GU malignancies with particular reference to cytotoxic agents, sphingolipids, and boron-containing compounds. He holds a U.S. patent for BNCT in prostate cancer and sphingolipid derivatives and their use.
Dr. Keane’s research has led to publication of more than 100 articles peer-reviewed in such journals as Cancer Research, he Journal of Urology, Urologic Oncology, and the Journal of Clinical Investigation. He provides editorial services to publications ranging from Urology to the International Journal of Cancer and is coeditor of the text Glenn’s Urologic Surgery, 6th, 7th, and 8th Edition. He is an accomplished speaker, having delivered many presentations to professional societies and symposia throughout the United States and abroad.
E. David Crawford
Dr. Crawford is the distinguished Professor of Surgery, Urology, and Radiation Oncology, and head of the Section of Urologic Oncology at the University of Colorado Anschutz Medical Campus. He is an active clinician, researcher, and teacher. He has been recognized as one of the Best Doctors in America, one of the Best Cancer Doctors, one of the Top 20 Urologists in the county by Men's Health Magazine, and recently selected as the Healthcare Provider of the Year in the Denver Metro Area by The Denver Business Journal. In addition, he is the recipient of more than 95 research grants in the diagnosis and treatment of prostate cancer, metastatic prostate cancer, hormone refractory prostate cancer, benign prostatic hyperplasia (BPH), advanced bladder cancer, and other areas of urological infections and malignancies
Petros Grivas, M.D.; Ph.D. is the Associate Staff, Department of Hematology / Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Ohio and the Clinical Assistant Professor of Medicine, Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Dr. Grivas is involved in clinical and translational research on experimental therapeutics in genitourinary cancers via a molecular biology-based approach aiming to translate results into clinical trials. At Cleveland Clinical Dr. Grivas and his team have built a comprehensive bladder/urothelial cancer clinical database and established a prospective bio-repository with tissue, blood, urine from patients with bladder/urothelial cancer. As a member of the Community Outreach Committees at Cleveland Clinic and Case Comprehensive Cancer Center; he is also leading the research program of the Community Outreach Committee at the Cleveland Clinic.
Ashish M. Kamat, MD is a Professor (Tenure) of Urology and Director of Urologic Oncology Fellowship at M.D. Anderson Cancer Center, and a graduate of the AUA Leadership Program. Dr Kamat has authored over 200 publications, editorials & book chapters in prestigious journals; he is listed in 'Who's Who in Medicine' and ‘Best Doctors in America’ and has won the Compassionate Doctor Award from patient groups. He is an exceptional educator nominated twice for the Robert M. Chamberlain Distinguished Mentor Award and has been invited as a visiting professor to several universities across the world. Dr Kamat is Co President,International Bladder Cancer Network, Chair, Bladder Cancer Think Tank (2015), Chair, Bladder Cancer Task Force for SITC, actively participates in various global urologic efforts, and serves on the board of regional and national societies for Urology.
Phillip J. Koo, MD is the Division Chief of Diagnostic Imaging at the Banner MD Anderson Cancer Center in Arizona. Prior to this, he was Chief of Nuclear Medicine and Associate Professor of Radiology at the University of Colorado School of Medicine. Dr. Koo completed his transitional internship at the University of Pennsylvania Medical Center-Presbyterian, radiology residency at Pennsylvania Hospital of the University of Pennsylvania Health System, and fellowship at the Harvard Medical School Joint Program in Nuclear Medicine. He is a diplomate of both the American Board of Radiology (ABR) and American Board of Nuclear Medicine. Dr. Koo is an active member of multiple societies and serves on the scientific program committee for the Radiological Society of North America, nuclear radiology certifying exam committee for the ABR, and is the Chair of the Quality and Evidence Committee for the Society of Nuclear Medicine and Molecular Imaging.
Dr. Jaime Landman has served as the chair of the Department of Urology since January 2011. He brings to UC Irvine Medical Center highly valued expertise from his former position as the director of minimally invasive urology in the Department of Urology at Columbia University College of Physicians and Surgeons in New York. Dr. Landman has extensive clinical expertise in laparoscopic and endoscopic kidney surgery for the management of urinary tract pathology including kidney stones, kidney cancer and ureteropelvic junction obstruction. He has pioneered technologies and techniques for minimally invasive management of kidney stones and kidney tumors and has developed novel techniques that are used globally for laparoscopic partial nephrectomy, ureteroscopy and percutaneous nephrolithotomy.
Alicia Morgans, MD, MPH is an Associate Professor of Medicine in the Division of Hematology/Oncology at the Northwestern University Feinberg School of Medicine in Chicago, Illinois. She completed her MD and internal medicine residency at the University Of Pennsylvania Perelman School Of Medicine, and her fellowship at Dana Farber Cancer Institute/MGH Cancer Center. She is a clinician and physician investigator specializing is investigating complications of systemic therapy for prostate cancer survivors. Her work has included the study of skeletal, cardiovascular, diabetic, and cognitive complications of prostate cancer survivorship, as well as treatment decision making in the metastatic prostate cancer population. She has expertise in clinical trials and patient reported outcome measures, and as well as incorporating patient preferences and beliefs into clinical decision making.
Charles J. Ryan, MD is Professor of Clinical Medicine and Urology and the Clinical Program Leader for Genitourinary Medical Oncology at the UCSF Helen Diller Family Comprehensive Cancer Center. He received his MD from the University of Wisconsin in Madison and completed his residency in internal medicine at the University of Wisconsin Hospital and Clinics, where he also served as Chief Resident. He completed a fellowship in medical oncology in the Department of Medicine at Memorial Sloan-Kettering Cancer Center and the Joan and Sanford I. Weill Medical College of Cornell University in New York.
Professor at the Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA
Karl-Erik Andersson, MD, PhD was born and raised in Sweden. He received his medical degree from the University of Lund in 1968, where he subsequently worked as a lecturer in clinical pharmacology. He completed his PhD at the Department of Pharmacology, Lund University, in 1973. In 1975 he obtained a Swedish specialist degree in Internal Medicine and was appointed Professor of Clinical Pharmacology at the University of Odense, Denmark. From 1976 to 1978 he also held the same position at the University of Aarhus, Denmark. From 1978-2006 he was Professor and Chairman of the Department of Clinical Pharmacology, University of Lund, Lund, Sweden. He has been visiting professor at the Department of Obstetrics and Gynecology, University of Toronto (1983-1985) and at the Department of Urology, University of Virginia, Charlottesville, USA (1997-1998). From 1993 to 2000 Dr. Andersson was Research Dean of the Medical Faculty at the University of Lund. Since 2006 he is Professor at the Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA. Dr. Andersson is a member of many international societies including the American Urological Association, the European Association of Urology, and the International Society for Sexual Medicine. He also serves on the Editorial Boards of several journals, including Journal of Urology, Urology, European Urology, and Neurourology and Urodynamics.
Dr. Andersson is Editor-in-Chief of UroToday International Journal. During his career, he has authored more than 700 articles in peer-reviewed international journals. His research interests include urogenital and cardiovascular pharmacology and physiology, clinical trials, and regenerative pharmacology.
John M. Fitzpatrick
Professor and Chairman of the Department of Surgery, Mater Misericordiae Hospital and University College, Dublin, Ireland
John M. Fitzpatrick, MD MCh, FRCSI, FC Urol (SA), FRCSGlas, FRCS was born and educated in Dublin. He qualified as a doctor in 1971 and became fellow of the Royal College of Surgeons in Ireland in 1975. He received his master's degree in 1976. He is also a fellow of the Royal College of Surgeons of England and of Glasgow. Between 1977 and 1981, Professor Fitzpatrick trained in the St. Peters Hospitals and the Institute of Urology in London. In 1981, Professor Fitzpatrick returned to Dublin as Consultant Urologist and Senior Lecturer in Urology in the Meath and St. James' Hospitals and Trinity College Dublin. In 1986, he was appointed Professor and Chairman of the Department of Surgery in the Mater Misericordiae Hospital and University College Dublin.
Professor Fitzpatrick has performed 45 visiting professorships in the United States and other countries throughout the world. He has also given 167 guest lectures throughout the world. He has produced 260 peer-reviewed publications, 74 book chapters, has edited 6 journal editions, and published 12 books. Professor Fitzpatrick is on the editorial board of 25 journals, and is Editor-in-Chief of the British Journal of Urology International. He is President of the Irish Society Urology and is Past President of the British Association of Urological Surgeons. He is a member of the Board of Trustees of the British Urological Foundation and is Chairman of the Scientific Committee of that Foundation. He is an Honorary Fellow of the College of Urologists of South Africa and an honorary member of the British Association of Urological Surgeons and of the American Urological Association as well as an honorary member of the Urological Societies of Australasia, South Africa, Germany, Netherlands, Hungary, Argentina, Greece, and Georgia.###
George W. Drach
Professor of Urology and Director of Outpatient Urology Education, University of Pennsylvania, Philadelphia, PA USA
George W. Drach, MD, FACS has served as Professor of Urology and Director of Outpatient Urology Education at the University of Pennsylvania since 1998. From 1996 to 1998, he visited the University of Texas Southwestern Medical School in Dallas as Professor of Urology and directed the Urology Clinic at Parkland Memorial Hospital. During the period 1970 - 1996 he resided at the University of Arizona, where he still holds the title of Professor Emeritus of Surgery/Urology and Founding Chief of Urology. Dr. Drach received his medical degree at Case Western Reserve University, Cleveland, Ohio, and then spent two years in surgical training at University Hospitals of Cleveland. His training was interrupted by two years of active duty in the US Navy, part of which time was spent as Chief Medical Officer of the aircraft carrier USS Valley Forge. Upon returning to civilian activity, he completed one year of fellowship in urology (endocrinology) and three years of urology residency under Dr. William Boyce at Wake Forest University in North Carolina. He completed his training in 1969, and then completed a medical fellowship at the University of New Mexico. He subsequently moved to his position at the University of Arizona.
He is the author of over 112 journal articles, 33 book chapters and 3 books or monographs. He functioned as editor of the American Urological Association (AUA) CME Interactive Education series on Patient Management Problems from 1996 to 2003 and was Chairman of the AUA Publications Committee from 1985 - 1987. He has served nationally as president of many organizations, including the Western Section AUA, the American Board of Urology, the Residency Review Committee for Urology, the Society of University Urologists, the Clinical Society of Genitourinary Surgeons, and the Society for Research on Calculous Kinetics (the ROCK Society). He received the AUA Hugh Hampton Young (outstanding contributions to American urology) and AUA Research Innovator (significant contributions to research) and Certificate of (Lifetime) Achievement awards in 1986, 1990, and 2004, respectively. He served as the Study Monitor for the United States Lithotripter Study (Dornier, Inc. and the National Electrical Manufacturers Assn.) 1982 - 1996, and received the honor of "Father of American Lithotripsy" in 1993. His major research interests include urinary stone disease, urinary and prostatic infections, mechanisms of urinary flow change with aging, and geriatric urology. As a result of this latter interest, he is now Chairman of the AUA Committee for Geriatric Urology, and Past-President of the Geriatric Urological Society. He also serves within the American Geriatric Society as Chairman of the Section on Surgery and Related Medical Specialties.###
Alan J. Wein
Professor and Chair Division of Urology University of Pennsylvania School of Medicine Chief of Urology Hospital of the University of Pennsylvania Philadelphia, PA USA
Alan J. Wein, MD, PhD (Hon.) is professor and chair of the Division of Urology at the University of Pennsylvania School of Medicine and Chief of Urology at the Hospital of the University of Pennsylvania. He is a graduate of Princeton University and received his MD from the University of Pennsylvania School of Medicine. He completed training in Surgery and Urology at the University of Pennsylvania including a fellowship at the Harrison Department of Surgical Research. He has been certified and recertified by the American Board of Urology. He was awarded an honorary Ph.D. from the University of Patras, Greece in September 2005.
Dr. Wein has been recognized nationally and internationally through his many affiliations and professional memberships which include the American Association of Genitourinary Surgeons, Clinical Society of Genitourinary Surgeons, American Surgical Association, Society of Surgical Oncology, Society of Urologic Oncology, Society of Pelvic Surgeons, Society for Urodynamics and Female Urology, Société Internationale d’Urologie, American Urological Association (AUA) and the Royal Society of Medicine. He is a recipient of the Urodynamics Society Lifetime Achievement Award, the F. Brantley Scott Award of the American Foundation for Urologic Diseases, the Hugh Hampton Young Award of the American Urological Association, and both the Distinguished Service Award and the Distinguished Contribution Award of the American Urological Association. He has been the Ramon Guiteras lecturer at the AUA annual meeting, the AUA lecturer of the Société Internationale d’Urologie and the European Association of Urology and the British Journal of Urology lecturer at the British Association of Urological Surgeons. He has served on and chaired numerous medical committees and consultations both domestically and internationally, and has received numerous awards and honors for excellence in the field of Urology. He has held or does hold editorial positions on many well-respected journals including the Journal of Urology, Survey Section of the Journal of Urology, Neurourology and Urodynamics, Urology, British Journal of Urology International, International Urogynecology Journal, Current Urology Reports, Current Opinion in Urology, Nature Urology and Current Bladder Dysfunction Reports. He has been an editor of the gold standard text in the field, Campbell’s Urology, since 1992 and is currently the editor-in-chief.
Dr. Wein has authored or co-authored more than 830 articles and chapters, edited or co-edited 24 books, and has multiple multimedia presentations to his credit. His extensive experience in the field of urology has afforded him the opportunity to participate in academic activities, meetings, and courses as a speaker, faculty member and chairperson. He is a prodigious lecturer with over 600 invited academic activities over the course of his career, including the co-chairmanship of the 1st, 2nd, 3rd and 4th International Consultations on Incontinence. His fields of interest lie in urologic oncology, the physiology and pharmacology of the lower urinary tract, the evaluation and management of voiding function and dysfunction, and urinary incontinence.